公司互动丨这些公司披露在医药生物、机器人等方面最新情况

Pharmaceutical Sector - Changchun Gaoxin's new drug for treating developmental disorders in boys has significantly impacted its stock price, but the company has stated that the project is still in the early stages [1] - Boya Bio plans to focus its future research on gene therapy and antibody drugs [1] Robotics Sector - Liard's robotics business falls under the AI and spatial computing segment, contributing approximately 5% to total revenue [1] - Liard has established partnerships with several well-known domestic and international robotics manufacturers [1] - Sanrui Technology's intelligent sensor chips are not applied in humanoid robots [1] Battery Sector - Wanshun New Materials has begun small-scale supply of aluminum foil for high-capacity batteries [1] Chemical Sector - Yahua Group reports that the current export ban in Zimbabwe will not affect its normal production and operations [1] - Dongyue Silicon Material is actively engaging the market with its liquid glue products [1]